Evidence map›Paper›PMID 33079429›Full record

ArticleThe Journal of pathology2021

Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions.

Isidoro Cobo, Mar Iglesias, Marta Flández, Caroline Verbeke, Natalia Del Pozo, Miriam Llorente, Rita Lawlor, Claudio Luchini, Borislav Rusev, Aldo Scarpa and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Allelic effects onmedRxiv : the preprint server for health sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.Biochimica et biophysica acta. Reviews on cancer · 2023
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Isidoro CoboEpithelial Carcinogenesis Group, Spanish National Cancer Research Centre - CNIO, Madrid, Spain.
Mar IglesiasCIBERONC, Madrid, Spain.
Marta FlándezEpithelial Carcinogenesis Group, Spanish National Cancer Research Centre - CNIO, Madrid, Spain.
Caroline VerbekeDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Natalia Del PozoEpithelial Carcinogenesis Group, Spanish National Cancer Research Centre - CNIO, Madrid, Spain.
Miriam LlorenteEpithelial Carcinogenesis Group, Spanish National Cancer Research Centre - CNIO, Madrid, Spain.
Rita LawlorARC - Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Claudio LuchiniARC - Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Borislav RusevARC - Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Aldo ScarpaARC - Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.ORCID 0000-0003-1678-739X
Francisco X RealEpithelial Carcinogenesis Group, Spanish National Cancer Research Centre - CNIO, Madrid, Spain.ORCID 0000-0001-9501-498X
Spanish National Cancer Research Centre · ESUniversity of Verona · ITOslo University Hospital · NOUniversitat Autònoma de Barcelona · ESUniversitat Pompeu Fabra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic neoplasms of the pancreas are an increasingly important public health problem. The majority of these lesions are benign but some progress to invasive pancreatic ductal adenocarcinoma (PDAC). There is a dearth of mouse models of these conditions. The orphan nuclear receptor NR5A2 regulates development, differentiation, and inflammation. Germline Nr5a2 heterozygosity sensitizes mice to the oncogenic effects of mutant Kras in the pancreas. Here, we show that - unlike constitutive Nr5a2

Indexed as

AdultAgedAged, 80 and overAnimalsCarcinoma, Pancreatic DuctalDisease ProgressionEpithelial CellsFemaleHeterozygoteHumansMaleMiceMiddle AgedPancreatic CystPancreatic DuctsPancreatic NeoplasmsHras protein, mouseKRAS protein, humanNR5A2 protein, humanNr5a2 protein, mouseProto-Oncogene Proteins p21(ras)Receptors, Cytoplasmic and Nuclearcystic neoplasmsgenetic mouse modelshaploinsufficiencyKRASNR5A2orphan receptorspancreas

Identifiers

PMID33079429
OpenAlexW3092966526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.